Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1962 2
1963 3
1964 7
1965 5
1967 2
1969 1
1971 1
1972 2
1973 2
1974 2
1975 4
1976 6
1977 14
1978 6
1979 13
1980 17
1981 20
1982 11
1983 25
1984 23
1985 31
1986 28
1987 29
1988 43
1989 43
1990 46
1991 50
1992 44
1993 50
1994 58
1995 85
1996 91
1997 94
1998 108
1999 116
2000 108
2001 119
2002 144
2003 145
2004 169
2005 153
2006 150
2007 183
2008 188
2009 183
2010 218
2011 226
2012 213
2013 268
2014 238
2015 264
2016 276
2017 259
2018 240
2019 241
2020 319
2021 340
2022 204
Text availability
Article attribute
Article type
Publication date

Search Results

5,388 results
Results by year
Filters applied: . Clear all
Page 1
Ocular Adverse Events After COVID-19 Vaccination.
Ng XL, Betzler BK, Testi I, Ho SL, Tien M, Ngo WK, Zierhut M, Chee SP, Gupta V, Pavesio CE, de Smet MD, Agrawal R. Ng XL, et al. Among authors: ho sl. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1216-1224. doi: 10.1080/09273948.2021.1976221. Epub 2021 Sep 24. Ocul Immunol Inflamm. 2021. PMID: 34559576 Free PMC article. Review.
Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer.
Kumar V, Ramnarayanan K, Sundar R, Padmanabhan N, Srivastava S, Koiwa M, Yasuda T, Koh V, Huang KK, Tay ST, Ho SWT, Tan ALK, Ishimoto T, Kim G, Shabbir A, Chen Q, Zhang B, Xu S, Lam KP, Lum HYJ, Teh M, Yong WP, So JBY, Tan P. Kumar V, et al. Among authors: ho swt. Cancer Discov. 2022 Mar 1;12(3):670-691. doi: 10.1158/2159-8290.CD-21-0683. Cancer Discov. 2022. PMID: 34642171
COVID-19 under 19: A meta-analysis.
Toba N, Gupta S, Ali AY, ElSaban M, Khamis AH, Ho SB, Popatia R. Toba N, et al. Among authors: ho sb. Pediatr Pulmonol. 2021 Jun;56(6):1332-1341. doi: 10.1002/ppul.25312. Epub 2021 Feb 25. Pediatr Pulmonol. 2021. PMID: 33631060 Free PMC article.
COVID-19 and healthcare workers: A systematic review and meta-analysis.
Gholami M, Fawad I, Shadan S, Rowaiee R, Ghanem H, Hassan Khamis A, Ho SB. Gholami M, et al. Among authors: ho sb. Int J Infect Dis. 2021 Mar;104:335-346. doi: 10.1016/j.ijid.2021.01.013. Epub 2021 Jan 11. Int J Infect Dis. 2021. PMID: 33444754 Free PMC article.
Sphingolipids control dermal fibroblast heterogeneity.
Capolupo L, Khven I, Lederer AR, Mazzeo L, Glousker G, Ho S, Russo F, Montoya JP, Bhandari DR, Bowman AP, Ellis SR, Guiet R, Burri O, Detzner J, Muthing J, Homicsko K, Kuonen F, Gilliet M, Spengler B, Heeren RMA, Dotto GP, La Manno G, D'Angelo G. Capolupo L, et al. Among authors: ho s. Science. 2022 Apr 15;376(6590):eabh1623. doi: 10.1126/science.abh1623. Epub 2022 Apr 15. Science. 2022. PMID: 35420948
Transformative Network Modeling of Multi-omics Data Reveals Detailed Circuits, Key Regulators, and Potential Therapeutics for Alzheimer's Disease.
Wang M, Li A, Sekiya M, Beckmann ND, Quan X, Schrode N, Fernando MB, Yu A, Zhu L, Cao J, Lyu L, Horgusluoglu E, Wang Q, Guo L, Wang YS, Neff R, Song WM, Wang E, Shen Q, Zhou X, Ming C, Ho SM, Vatansever S, Kaniskan HÜ, Jin J, Zhou MM, Ando K, Ho L, Slesinger PA, Yue Z, Zhu J, Katsel P, Gandy S, Ehrlich ME, Fossati V, Noggle S, Cai D, Haroutunian V, Iijima KM, Schadt E, Brennand KJ, Zhang B. Wang M, et al. Among authors: ho sm. Neuron. 2021 Jan 20;109(2):257-272.e14. doi: 10.1016/j.neuron.2020.11.002. Epub 2020 Nov 24. Neuron. 2021. PMID: 33238137 Free PMC article.
Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.
Koong LR, Chee WK, Toh ZH, Ng XL, Agrawal R, Ho SL. Koong LR, et al. Among authors: ho sl. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1212-1215. doi: 10.1080/09273948.2021.1974492. Epub 2021 Sep 10. Ocul Immunol Inflamm. 2021. PMID: 34505819
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer.
LaMarche MJ, Acker M, Argintaru A, Bauer D, Boisclair J, Chan H, Chen CH, Chen YN, Chen Z, Deng Z, Dore M, Dunstan D, Fan J, Fekkes P, Firestone B, Fodor M, Garcia-Fortanet J, Fortin PD, Fridrich C, Giraldes J, Glick M, Grunenfelder D, Hao HX, Hentemann M, Ho S, Jouk A, Kang ZB, Karki R, Kato M, Keen N, Koenig R, LaBonte LR, Larrow J, Liu G, Liu S, Majumdar D, Mathieu S, Meyer MJ, Mohseni M, Ntaganda R, Palermo M, Perez L, Pu M, Ramsey T, Reilly J, Sarver P, Sellers WR, Sendzik M, Shultz MD, Slisz J, Slocum K, Smith T, Spence S, Stams T, Straub C, Tamez V Jr, Toure BB, Towler C, Wang P, Wang H, Williams SL, Yang F, Yu B, Zhang JH, Zhu S. LaMarche MJ, et al. Among authors: ho s. J Med Chem. 2020 Nov 25;63(22):13578-13594. doi: 10.1021/acs.jmedchem.0c01170. Epub 2020 Sep 24. J Med Chem. 2020. PMID: 32910655
Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14).
Bahlis NJ, Baz R, Harrison SJ, Quach H, Ho SJ, Vangsted AJ, Plesner T, Moreau P, Gibbs SD, Coppola S, Yang X, Al Masud A, Ross JA, Bueno O, Kaufman JL. Bahlis NJ, et al. Among authors: ho sj. J Clin Oncol. 2021 Nov 10;39(32):3602-3612. doi: 10.1200/JCO.21.00443. Epub 2021 Aug 13. J Clin Oncol. 2021. PMID: 34388020 Clinical Trial.
5,388 results